These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 20926112

  • 21. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
    Cihan-Üstündağ G, Zopun M, Vanderlinden E, Ozkirimli E, Persoons L, Çapan G, Naesens L.
    Bioorg Med Chem; 2020 Jan 01; 28(1):115130. PubMed ID: 31753804
    [Abstract] [Full Text] [Related]

  • 22. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Jan 20; 55(2):44-6. PubMed ID: 16424859
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.
    Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, Holmes EC.
    Mol Biol Evol; 2007 Aug 20; 24(8):1811-20. PubMed ID: 17522084
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
    Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC.
    Virology; 2009 Jun 05; 388(2):270-8. PubMed ID: 19394063
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Adamantane resistance in influenza A.
    Weinstock DM, Zuccotti G.
    JAMA; 2006 Feb 22; 295(8):934-6. PubMed ID: 16493107
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M, Xu L, Lin D, Lian W, Cui M, Zhang M, Yan X, Li S, Zhao J, Ye J, Liu A, Hu A.
    Eur J Med Chem; 2021 Mar 05; 213():113161. PubMed ID: 33540229
    [Abstract] [Full Text] [Related]

  • 37. Heterocyclic rimantadine analogues with antiviral activity.
    Zoidis G, Fytas C, Papanastasiou I, Foscolos GB, Fytas G, Padalko E, De Clercq E, Naesens L, Neyts J, Kolocouris N.
    Bioorg Med Chem; 2006 May 15; 14(10):3341-8. PubMed ID: 16439137
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The relative potencies of anti-influenza compounds.
    Tisdale M, Bauer DJ.
    Ann N Y Acad Sci; 1977 Mar 04; 284():254-63. PubMed ID: 280137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.